Signal Advisors Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Buy
3,645
+837
+30% +$67.5K 0.01% 542
2026
Q1
$243K Buy
+2,808
New +$269K 0.02% 523
2025
Q1
Sell
-3,652
Closed -$294K 452
2024
Q4
$294K Sell
3,652
-394
-10% -$34.1K 0.03% 362
2024
Q3
$364K Buy
+4,046
New +$340K 0.05% 310
2024
Q2
Sell
-3,633
Closed -$317K 209
2024
Q1
$317K Buy
3,633
+911
+33% +$77.7K 0.08% 228
2023
Q4
$226K Buy
+2,722
New +$207K 0.08% 202

Other funds holding MDT

Signal Advisors Wealth's MDT Position: Q2 2026 in Review

Signal Advisors Wealth increased its Medtronic (MDT) stake by 30% in Q2 2026, buying an estimated $67.5K and bringing the position to 3,645 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #542.

Signal Advisors Wealth first reported a position in MDT in Q4 2023 and has held it in 6 quarters since. The position peaked at $364K in Q3 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Signal Advisors Wealth held 3,645 shares of Medtronic worth $285K as of Q2 2026.
  • Signal Advisors Wealth bought 837 Medtronic shares in Q2 2026, an estimated $67.5K.
  • Medtronic made up 0.01% of Signal Advisors Wealth's portfolio in Q2 2026, its #542 holding.
  • Signal Advisors Wealth first reported a position in Medtronic in Q4 2023 and has held it in 6 quarters since.
  • Signal Advisors Wealth's Medtronic position peaked at $364K in Q3 2024.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.